Search Results
Search for other papers by Cristina L Ronchi in
Google Scholar
PubMed
Search for other papers by Silviu Sbiera in
Google Scholar
PubMed
Search for other papers by Barbara Altieri in
Google Scholar
PubMed
Search for other papers by Sonja Steinhauer in
Google Scholar
PubMed
Endocrine and Diabetes Unit, Central Laboratory, Institute of Pathology, Comprehensive Cancer Center Mainfranken, Department of Internal Medicine I, University Hospital, University of Wuerzburg, Oberrduerrbacher-Strasse 6, 97080 Wuerzburg, Germany
Search for other papers by Vanessa Wild in
Google Scholar
PubMed
Search for other papers by Michaela Bekteshi in
Google Scholar
PubMed
Search for other papers by Matthias Kroiss in
Google Scholar
PubMed
Search for other papers by Martin Fassnacht in
Google Scholar
PubMed
Search for other papers by Bruno Allolio in
Google Scholar
PubMed
study that employed SNP array profiling in adrenocortical tumors (ACTs), we identified the Notch1 signaling pathway as being the most frequently altered pathway in both ACAs and ACCs, followed by alterations in Wnt/β-catenin signaling ( Ronchi et al
Search for other papers by Y Capodanno in
Google Scholar
PubMed
Search for other papers by F O Buishand in
Google Scholar
PubMed
Search for other papers by L Y Pang in
Google Scholar
PubMed
Search for other papers by J Kirpensteijn in
Google Scholar
PubMed
Search for other papers by J A Mol in
Google Scholar
PubMed
Search for other papers by D J Argyle in
Google Scholar
PubMed
INS cells and CSC-enriched tumour spheres. We showed that the Notch pathway is a critical pathway involved in INS CSC viability. Using both in vitro and in vivo models, we have demonstrated the efficacy of targeting the Notch pathway in decreasing
Search for other papers by Gerard A Tarulli in
Google Scholar
PubMed
Search for other papers by Lisa M Butler in
Google Scholar
PubMed
Search for other papers by Wayne D Tilley in
Google Scholar
PubMed
Search for other papers by Theresa E Hickey in
Google Scholar
PubMed
breast cancer. In this review, we focus on new knowledge about AR and NOTCH signalling in the normal breast and the potential for integration with NOTCH signalling in the context of breast tumourigenesis. Where and how do androgens act in the mammary
Search for other papers by Lautaro Zubeldía-Brenner in
Google Scholar
PubMed
Search for other papers by Catalina De Winne in
Google Scholar
PubMed
Search for other papers by Sofía Perrone in
Google Scholar
PubMed
CONICET-Universidad de Buenos Aires, Instituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE), Buenos Aires, Argentina
Search for other papers by Santiago A Rodríguez-Seguí in
Google Scholar
PubMed
Search for other papers by Christophe Willems in
Google Scholar
PubMed
Search for other papers by Ana María Ornstein in
Google Scholar
PubMed
Search for other papers by Isabel Lacau-Mengido in
Google Scholar
PubMed
Search for other papers by Hugo Vankelecom in
Google Scholar
PubMed
Search for other papers by Carolina Cristina in
Google Scholar
PubMed
Search for other papers by Damasia Becu-Villalobos in
Google Scholar
PubMed
these tumors may be aggressive, atypical or recurrent, and presently, there is a paucity of molecular markers that could improve diagnosis, treatment and prognosis. Stem-like cell activation of different components of the Notch pathway have been
Search for other papers by James F H Pittaway in
Google Scholar
PubMed
Search for other papers by Constantinos Lipsos in
Google Scholar
PubMed
Search for other papers by Katia Mariniello in
Google Scholar
PubMed
Search for other papers by Leonardo Guasti in
Google Scholar
PubMed
Introduction The first reported expression of the delta-like non-canonical Notch ligand 1 gene ( DLK1 ) was in 1987. An investigation into differential expression of genes in the development of neuroendocrine tissues identified a cDNA clone
Search for other papers by Brandi B Knight in
Google Scholar
PubMed
Search for other papers by Gabriela M Oprea-Ilies in
Google Scholar
PubMed
Search for other papers by Arumugam Nagalingam in
Google Scholar
PubMed
Department of Hematology and Medical Oncology, Department of Pathology and Laboratory Medicine, Emory Winship Cancer Institute, Department of Surgery, Department of Medicine, Department of Oncology, Emory University School of Medicine, Atlanta, Georgia 30322, USA
Search for other papers by Lily Yang in
Google Scholar
PubMed
Search for other papers by Cynthia Cohen in
Google Scholar
PubMed
Search for other papers by Neeraj K Saxena in
Google Scholar
PubMed
Search for other papers by Dipali Sharma in
Google Scholar
PubMed
breast cancer cells and examined the underlying molecular mechanisms by which leptin upregulates survivin expression. Intriguingly, we discovered the involvement of a novel upstream leptin–epidermal growth factor receptor (EGFR)–Notch1 axis in survivin
Search for other papers by Charles E Massie in
Google Scholar
PubMed
Search for other papers by Inmaculada Spiteri in
Google Scholar
PubMed
Search for other papers by Helen Ross-Adams in
Google Scholar
PubMed
Search for other papers by Hayley Luxton in
Google Scholar
PubMed
Search for other papers by Jonathan Kay in
Google Scholar
PubMed
Search for other papers by Hayley C Whitaker in
Google Scholar
PubMed
Search for other papers by Mark J Dunning in
Google Scholar
PubMed
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Search for other papers by Alastair D Lamb in
Google Scholar
PubMed
Search for other papers by Antonio Ramos-Montoya in
Google Scholar
PubMed
Search for other papers by Daniel S Brewer in
Google Scholar
PubMed
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Search for other papers by Colin S Cooper in
Google Scholar
PubMed
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Search for other papers by Rosalind Eeles in
Google Scholar
PubMed
Search for other papers by UK Prostate ICGC Group in
Google Scholar
PubMed
Search for other papers by Anne Y Warren in
Google Scholar
PubMed
Search for other papers by Simon Tavaré in
Google Scholar
PubMed
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Search for other papers by David E Neal in
Google Scholar
PubMed
Search for other papers by Andy G Lynch in
Google Scholar
PubMed
development ( Hatakeyama et al . 2004 , Tateya et al . 2011 ), with HES5 -null cells promoting an imbalance in intestinal and neural stem cell fate choices resulting from defective NOTCH signalling ( Sancho et al . 2013 ). Intriguingly defective NOTCH
Search for other papers by Hongyu Chen in
Google Scholar
PubMed
Search for other papers by Dan Liu in
Google Scholar
PubMed
Search for other papers by Zhengyan Yang in
Google Scholar
PubMed
Search for other papers by Limin Sun in
Google Scholar
PubMed
Search for other papers by Que Deng in
Google Scholar
PubMed
Search for other papers by Shuo Yang in
Google Scholar
PubMed
Search for other papers by Lu Qian in
Google Scholar
PubMed
Search for other papers by Liang Guo in
Google Scholar
PubMed
Search for other papers by Ming Yu in
Google Scholar
PubMed
Search for other papers by Meiru Hu in
Google Scholar
PubMed
Search for other papers by Ming Shi in
Google Scholar
PubMed
Search for other papers by Ning Guo in
Google Scholar
PubMed
between the tumor and angiogenic endothelial cells significantly influences tumor growth and angiogenesis. An evolutionarily conserved Notch signal that regulates short-range intercellular interactions has been implicated in the control of vasculogenesis
Search for other papers by Feng Xu in
Google Scholar
PubMed
Search for other papers by Yali Ling in
Google Scholar
PubMed
Search for other papers by Jingjing Yuan in
Google Scholar
PubMed
Search for other papers by Qin Zeng in
Google Scholar
PubMed
Search for other papers by Lusha Li in
Google Scholar
PubMed
Search for other papers by Dexing Dai in
Google Scholar
PubMed
Search for other papers by Xuedi Xia in
Google Scholar
PubMed
Search for other papers by Ruoman Sun in
Google Scholar
PubMed
Search for other papers by Ran Zhang in
Google Scholar
PubMed
Search for other papers by Zhongjian Xie in
Google Scholar
PubMed
inhibition of p38 MAPK blocked 1,25(OH) 2 D 3 -induced Notch3 expression and knockdown of Notch3 blocked 1,25(OH) 2 D 3 -inhibited proliferation of K1 and WRO cells C/EBPβ functions by acting as a transcription factor that regulates the expression of
Search for other papers by Antonella Verrienti in
Google Scholar
PubMed
Search for other papers by Giovanni Tallini in
Google Scholar
PubMed
Search for other papers by Chiara Colato in
Google Scholar
PubMed
Search for other papers by Amélie Boichard in
Google Scholar
PubMed
Search for other papers by Saula Checquolo in
Google Scholar
PubMed
Search for other papers by Valeria Pecce in
Google Scholar
PubMed
Search for other papers by Marialuisa Sponziello in
Google Scholar
PubMed
Search for other papers by Francesca Rosignolo in
Google Scholar
PubMed
Search for other papers by Dario de Biase in
Google Scholar
PubMed
Search for other papers by Kerry Rhoden in
Google Scholar
PubMed
Search for other papers by Gian Piero Casadei in
Google Scholar
PubMed
Search for other papers by Diego Russo in
Google Scholar
PubMed
Search for other papers by Michela Visani in
Google Scholar
PubMed
Search for other papers by Giorgia Acquaviva in
Google Scholar
PubMed
Search for other papers by Marco Ferdeghini in
Google Scholar
PubMed
Search for other papers by Sebastiano Filetti in
Google Scholar
PubMed
Search for other papers by Cosimo Durante in
Google Scholar
PubMed
Scientific) for the main components of the Notch pathway (receptors: NOTCH1, 2, 3, 4 ; ligands: DLL1, DLL3, DLL4, JAG1, JAG2 ; regulators: the gamma-secretases PSEN1 and 2 , DTX1, MAML1 and RBPJ ; effectors: HES1, HEY1-2-L; the repressor NUMB